Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
1.22%Interest Expense Margin
VS
Market
Sector
Industry
History
$ 3.15Close
$ 2.35 - $ 6.36 52-Week Range
Ticker Information
Ticker
OBIOCompany Name
ORCHESTRA BIOMED HOLDINGS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQORCHESTRA BIOMED HOLDINGS INC - Interest Expense Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
OBIO - Int. Exp. % Historical data
| Date | Interest Expense | Interest Expense Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 36K | 1.22% | $ 2.94M |
| 3/31/2025 | $ 0 | 0% | $ 2.89M |
| 12/31/2024 | $ 0 | 0% | $ 2.64M |
| 9/30/2024 | $ 2.74M | 103.55% | $ 2.65M |
| 6/30/2024 | $ 1.83M | 87.83% | $ 2.08M |
| 3/31/2024 | $ 885K | 39.94% | $ 2.22M |
| 12/31/2023 | $ 0 | 0% | $ 2.76M |
| 9/30/2023 | $ -3.21M | -89.14% | $ 3.6M |
| 9/30/2022 | $ 0 | 0% | $ 0 |
| 6/30/2022 | $ 0 | 0% | $ 0 |
Key Performance Insights, Last 5 Years
- ORCHESTRA BIOMED HOLDINGS INC's latest trailing twelve months (TTM) Int. Exp. % stands at 0%.
- Over the past 5 years, ORCHESTRA BIOMED HOLDINGS INC's average Int. Exp. % has been 17.92%.
- The median Int. Exp. % for ORCHESTRA BIOMED HOLDINGS INC during this period was 0.61%
- ORCHESTRA BIOMED HOLDINGS INC reached its highest Int. Exp. % over the past 5 years at 103.55%.
- The lowest Int. Exp. % recorded by ORCHESTRA BIOMED HOLDINGS INC in the same timeframe -89.14%
ORCHESTRA BIOMED HOLDINGS INC's Int. Exp. % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Int. Exp. % Benchmarks
Similar metrics to Revenues:
- Interest Expense - [Income Statement] Interest expense is the cost incurred by a business for borrowing funds.
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation and Amortization Margin - [Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].
Definition of Interest Expense Margin
[Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].Int. Exp. / Revenues
(=) Int. Exp. % Int. Exp. % for ORCHESTRA BIOMED HOLDINGS INC is calculated as follows: Int. Exp. [ $ 0 ] / Revenues [ $ 0 ]
(=) Int. Exp. % [ 0% ] OBIO - Interest Expense Margin, Last 5 years
-89.14%
Minimum
Sep 30, 2023
103.55%
Maximum
Sep 30, 2024
17.92%
Average
0.61%
Median
Int. Exp. % Benchmark AnalysisMarket
The chart above depicts the distribution of Int. Exp. % for companies in the Total Stock Market. The average Int. Exp. % of the companies is 1.62% with a standard deviation of 2.19%.
The following table provides additional summary stats:
Int. Exp. % in the Market:
| filtered constituents | 3.15K |
|---|---|
| min | -4.94% |
| max | 8.48% |
| average | 1.62% |
| median | 0.79% |
| std | 2.19% |